Home›People›Paul Finnegan
PF

Paul Finnegan

President/Chief Executive Officer and director at Angiocrine Bioscience.

ExecutiveDirector
Updated Oct 27, 2026·Latest SEC filing Sep 5, 2025·Suggest an edit

About Paul Finnegan

Paul Finnegan is a president/chief executive officer and director at Angiocrine Bioscience.

Paul Finnegan first appears on SEC filings in 2021.

Experience

This experience comes from SEC filings. The years are when the filings name Paul Finnegan in the role, so the role may have started earlier or lasted longer.

Angiocrine Bioscience, Inc.
President/Chief Executive Officer and director
2021 – 2025 · San Diego, CA

Key Colleagues at Startups

The people Paul Finnegan works with at each company, as listed on that company's latest Form D.

Angiocrine Bioscience, Inc. · Form D, Sep 5, 2025
DP
Jeffrey Port
Jeffrey Port
Director
JL
John Lomoro
Chief Financial Officer/Treasurer
JJ
John Jaskowiak
Chief Operating Officer/Secretary

Sources

  1. SECAngiocrine Bioscience, Inc. Form D, filed Sep 5, 2025